1-4 of 4
Daniela Donnarumma
Close
Sort by
Journal Articles

Edo-S101, a Bendamustine (BDM)/ Histone-Deacetylase Inhibitor (HDACi) Fusion Molecule, Demonstrates Potent Preclinical Activity Against T-Cell Malignancies and Overcomes BDM-Resistance

Rosaria De Filippi, MD PhD, Stefania Crisci, ScD, Sara Mele, BS, Serena Zanotta, ScD, Gaetano Corazzelli, MD, Domenico Galati, MD PhD, Davide Coppola, RN, Piera Maiolino, PharmD, Mariangela Saggese, PharmD, Francesco Volzone, MD, Emanuela Morelli, MD, Daniela Donnarumma, MD, Gianpaolo Marcacci, MD, Ferdinando Frigeri, MD, Niels Odum, MD, Thomas Mehrling, MD PhD, Antonio Pinto, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2547.
https://doi.org/10.1182/blood.V130.Suppl_1.2547.2547
Published: 2017
Journal Articles

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Michele Cavo, Lucia Pantani, Maria Teresa Petrucci, Francesca Patriarca, Elena Zamagni, Daniela Donnarumma, Claudia Crippa, Mario Boccadoro, Giulia Perrone, Antonietta Falcone, Chiara Nozzoli, Renato Zambello, Luciano Masini, Anna Furlan, Annamaria Brioli, Daniele Derudas, Stelvio Ballanti, Maria Laura Dessanti, Valerio De Stefano, Angelo Michele Carella, Magda Marcatti, Andrea Nozza, Felicetto Ferrara, Vincenzo Callea, Catello Califano, Annalisa Pezzi, Anna Baraldi, Mariella Grasso, Pellegrino Musto, Antonio Palumbo
Journal: Blood
Blood (2012) 120 (1): 9–19.
https://doi.org/10.1182/blood-2012-02-408898
Published: 2012
Includes: Supplemental data
Journal Articles

A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Carolina Terragna, PhD, Daniel Remondini, PhD, Sandra Durante, Marina Martello, Francesca Patriarca, MD, Anna Levi, Lucia Pantani, MD, Daniela Donnarumma, MD, Claudia Crippa, MD, Sara Bringhen, MD, Alessandro Rambaldi, Massimo Offidani, MD, Paolo Corradini, MD, Franco Narni, MD, Giuseppe Fioritoni, MD, Alfonso Zaccaria, Luca Baldini, MD, Tommaso Caravita, MD, Giorgio La Nasa, MD, Sergio Cortelazzo, MD, Giovanni Martinelli, MD, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 805.
https://doi.org/10.1182/blood.V118.21.805.805
Published: 2011
Journal Articles

Absolute Count of Myeloid Derived Suppressor Cells (MDSC) Is Able to Predict the Response to Early-PET In Hodgkin Lymphoma

Alessandra Romano, MD, Nunziatina Parrinello, Calogero Vetro, MD, Piera La Cava, PhD, Daniela Donnarumma, MD, Concetta Conticello, MD, Ugo Consoli, MD, Paolo Fiumara, MD, Annalisa Chiarenza, MD, Giuseppe A Palumbo, MD, Massimo Ippolito, MD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2010) 116 (21): 3882.
https://doi.org/10.1182/blood.V116.21.3882.3882
Published: 2010